𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine (GEM) and capecitabine (CAP) for advanced pancreatic cancer. A phase I/II trial

✍ Scribed by Hess, V.; Bomer, M.; Morant, R.; Roth, A.D.; Ludwig, C.; Herman, R.

Book ID
121970326
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
346 KB
Volume
37
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expanded phase II trial of gemcitabine a
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer
✍ Rachel P. Riechelmann; Carol A. Townsley; Sheray N. Chin; Gregory R. Pond; Jenni πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. A phase 2 trial of gemcitabine and capecitabine (GemCap) in patients with advanced biliary cancer led to an objective response in approximately 30% of patients and a median survival of 14 months. In the current study, the authors report further efficacy data of a larger